69800-94-8Relevant articles and documents
FERROPTOSIS INHIBITORS–DIARYLAMINE PARA-ACETAMIDES
-
Paragraph 0809; 0811; 0949; 0951, (2021/09/11)
Provided are compounds that inhibit ferroptosis activity, or modulate or inhibit a disease associated with ferroptosis dysregulation, such as neuropathy, ischemia reperfusion injury, acute kidney failure and cancer, including corresponding sulfonamides, and pharmaceutically acceptable salts, hydrates and stereoisomers thereof. The compounds are employed in pharmaceutical compositions, and methods of making and use, including treating a person in need thereof with an effective amount of the compound or composition, and detecting a resultant improvement in the person's health or condition.
A novel aromatic alkylation of anilines with cyclic and acyclic ketones under hydrothermal conditions
Mehta, Barun K.,Kumamoto, Koji,Yanagisawa, Kazumichi,Kotsuki, Hiyoshizo
, p. 6953 - 6956 (2007/10/03)
A novel aromatic ring-alkylation was achieved by condensation between aniline-HCl salts and cyclic or acyclic ketones under hydrothermal conditions.